Cargando…

The Delivery of mRNA Vaccines for Therapeutics

mRNA vaccines have been revolutionary in combating the COVID-19 pandemic in the past two years. They have also become a versatile tool for the prevention of infectious diseases and treatment of cancers. For effective vaccination, mRNA formulation, delivery method and composition of the mRNA carrier...

Descripción completa

Detalles Bibliográficos
Autores principales: Nitika, Wei, Jiao, Hui, Ai-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410089/
https://www.ncbi.nlm.nih.gov/pubmed/36013433
http://dx.doi.org/10.3390/life12081254
_version_ 1784775009667907584
author Nitika,
Wei, Jiao
Hui, Ai-Min
author_facet Nitika,
Wei, Jiao
Hui, Ai-Min
author_sort Nitika,
collection PubMed
description mRNA vaccines have been revolutionary in combating the COVID-19 pandemic in the past two years. They have also become a versatile tool for the prevention of infectious diseases and treatment of cancers. For effective vaccination, mRNA formulation, delivery method and composition of the mRNA carrier play an important role. mRNA vaccines can be delivered using lipid nanoparticles, polymers, peptides or naked mRNA. The vaccine efficacy is influenced by the appropriate delivery materials, formulation methods and selection of a proper administration route. In addition, co-delivery of several mRNAs could also be beneficial and enhance immunity against various variants of an infectious pathogen or several pathogens altogether. Here, we review the recent progress in the delivery methods, modes of delivery and patentable mRNA vaccine technologies.
format Online
Article
Text
id pubmed-9410089
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94100892022-08-26 The Delivery of mRNA Vaccines for Therapeutics Nitika, Wei, Jiao Hui, Ai-Min Life (Basel) Review mRNA vaccines have been revolutionary in combating the COVID-19 pandemic in the past two years. They have also become a versatile tool for the prevention of infectious diseases and treatment of cancers. For effective vaccination, mRNA formulation, delivery method and composition of the mRNA carrier play an important role. mRNA vaccines can be delivered using lipid nanoparticles, polymers, peptides or naked mRNA. The vaccine efficacy is influenced by the appropriate delivery materials, formulation methods and selection of a proper administration route. In addition, co-delivery of several mRNAs could also be beneficial and enhance immunity against various variants of an infectious pathogen or several pathogens altogether. Here, we review the recent progress in the delivery methods, modes of delivery and patentable mRNA vaccine technologies. MDPI 2022-08-17 /pmc/articles/PMC9410089/ /pubmed/36013433 http://dx.doi.org/10.3390/life12081254 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Nitika,
Wei, Jiao
Hui, Ai-Min
The Delivery of mRNA Vaccines for Therapeutics
title The Delivery of mRNA Vaccines for Therapeutics
title_full The Delivery of mRNA Vaccines for Therapeutics
title_fullStr The Delivery of mRNA Vaccines for Therapeutics
title_full_unstemmed The Delivery of mRNA Vaccines for Therapeutics
title_short The Delivery of mRNA Vaccines for Therapeutics
title_sort delivery of mrna vaccines for therapeutics
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410089/
https://www.ncbi.nlm.nih.gov/pubmed/36013433
http://dx.doi.org/10.3390/life12081254
work_keys_str_mv AT nitika thedeliveryofmrnavaccinesfortherapeutics
AT weijiao thedeliveryofmrnavaccinesfortherapeutics
AT huiaimin thedeliveryofmrnavaccinesfortherapeutics
AT nitika deliveryofmrnavaccinesfortherapeutics
AT weijiao deliveryofmrnavaccinesfortherapeutics
AT huiaimin deliveryofmrnavaccinesfortherapeutics